Preventing corneal abrasions in critically ill children receiving neuromuscular blockade: a randomized, controlled

Lauren R Sorce1, Susan M Hamilton, Kimberlee Gauvreau

  • 1Children's Memorial Hospital, Chicago, IL, USA. LSorce@childrensmemorial.org

Insights

Corneal abrasions are a significant risk for critically ill children on neuromuscular blockade (NMB). Moisture chambers did not prevent these eye injuries more effectively than standard lubrication and eye closure.

Area of Science:

  • Critical care medicine
  • Ophthalmology
  • Pediatrics

Background:

  • Critically ill children requiring neuromuscular blockade (NMB) are at risk for corneal abrasions.
  • Standard care involves lubrication and eye closure, but its efficacy in preventing abrasions is unclear.

Purpose of the Study:

  • To determine the incidence of corneal abrasions in critically ill children receiving NMB.
  • To compare the effectiveness of moisture chambers versus standard therapy in preventing corneal abrasions.

Main Methods:

  • Randomized controlled clinical trial conducted in three pediatric intensive care units.
  • Inclusion of intubated, mechanically ventilated patients aged 2 weeks to 18 years receiving NMB for less than 36 hours.
  • Randomization to either standard care (lubrication and eye closure) or treatment (lubrication, eye closure, and moisture chamber), with daily eye examinations.

Main Results:

  • 207 patients were randomized; 21 (10%) developed corneal abrasions.
  • The incidence of corneal abrasions was not significantly different between the control and treatment groups (p = 0.58).
  • Eight abrasions occurred in control eyes, five in treatment eyes, and eight in both eyes.

Conclusions:

  • Corneal abrasions are a non-trivial complication in critically ill children on NMB.
  • Moisture chambers offer no additional benefit over standard lubrication and eye closure for preventing corneal abrasions in this population.
Abstract

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...